Eversept Partners’s iTeos Therapeutics ITOS Stock Holding History

Eversept Partners’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-109,324	Closed	-$1.09M	–	94
2025 Q2	$1.09M	Sell	109,324 -110,872	-50%	-$893K	0.1%	62
2025 Q1	$1.31M	Hold	220,196	–	–	0.13%	50
2024 Q4	$1.69M	Buy	+220,196	New	+$1.89M	0.15%	57

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eversept Partners's ITOS Position: Q3 2025 in Review

Eversept Partners sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 109,324 shares — an estimated $1.09M sold.

Eversept Partners first reported a position in ITOS in Q4 2024 and held it in 3 quarters. The position peaked at $1.69M in Q4 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Eversept Partners reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Eversept Partners sold 109,324 iTeos Therapeutics shares in Q3 2025, an estimated $1.09M.
Eversept Partners first reported a position in iTeos Therapeutics in Q4 2024 and held it in 3 quarters.
Eversept Partners's iTeos Therapeutics position peaked at $1.69M in Q4 2024.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Eversept Partners's 13F filing for Q3 2025, filed 14 Nov 2025.